From: Multiresistant bacteria and current therapy - the economical side of the story
Parameter | Linezolid | Daptomycin | Doripenem | Tigecycline |
---|---|---|---|---|
LOS | X | X | X | Â |
HMV | Â | Â | X | Â |
ICU days | Â | Â | Â | Â |
Isolation | Â | Â | Â | Â |
Complications | Â | X | Â | Â |
Early choice | Â | Â | Â | Â |
IV-to-oral switch | X | Â | Â | (X)* |
Duration of therapy | X | (X) | Â | (X) |
Combination therapy | Â | Â | Â | X |
Adherence to guidelines | Â | Â | Â | Â |